Receive relevant New and Updated programmes: Personal Updates !
|Application deadline:||Non EEA January 15; EEA April 15|
|Tuition fee:|| |
|Start date:||September 2014|
|Credits:|| 120 ECTS |
|Duration full-time:||24 months|
|Delivery mode:||On Campus|
Development of new effective drugs is an important task for chemists. Examples of drugs that are produced with modern technology is L-DOPA (for Parkinsons disease) and Nexium (stomach ulcer medicine). Production methods behind these medications was awarded the 2001 Nobel Prize in Chemistry.
Swedish pharmaceutical industry will for a long time to come have a great need for qualified chemists in research and development. An important part of pharmaceutical research is to find new compounds with good therapeutic properties and to develop methods for their production. Masters Program in Medicinal Chemistry is for people who want to understand how the small drug molecules interact with biological systems to cure us when we become ill.
You will also learn how to design and manufacture of new drug tp become in the future super builder in the world of molecules. The program is a collaboration between the Department of Biochemistry and Biophysics, Department of Neurochemistry and the Department of Organic Chemistry. The training consists of compulsory courses of 60 credits in which two drug-specific courses (30 credits) is the base. Also included are at least three elective courses (45 credits) at an advanced level. The program ends with a compulsory independent project, involving at least 30 credits. In addition, other courses at university level can be taken. The program aims to provide knowledge about drugs and their effects in biological systems. The courses have a close link to pharmaceutical research in various host institutions.
* Medicinal Chemistry II (15 ECTS) KN8004
* and either of the following degree projects: ( ECTS)
* Organic chemistry, degree project (30 ECTS) KO9001
* Organic chemistry, degree project (45 ECTS) KO9003
* Degree project in biochemistry (30 ECTS) KB9013
* Degree project in biochemistry (45 ECTS) KB9014
* Neurochemistry with Molecular Neurobiology, Degree Project (30 ECTS) KN9001
* Neurochemistry with Molecular Neurobiology, Degree Project (45 ECTS) KN9002
* In addition to the compulsory courses there is a choice among specialized courses. A minimum of 45 hp should be selected among these. ( ECTS)
* Advanced organic synthesis (15 ECTS) KO7003
* Bioorganic structural analysis (15 ECTS) KO7001
* Organometallic chemistry - from chemical bonding to asymmetric catalysis (15 ECTS) KO7002
* Advanced organic chemistry (15 ECTS) KO8001
* Biochemical toxicology (15 ECTS) KB7001
* Advanced biochemical methods (15 ECTS) KB8002
* Structure and dynamics of biological membranes (15 ECTS) KB8001
* Peptides, Proteins and Proteomics (15 ECTS) KN7002
* Neurochemistry with Molecular Neurobiology (15 ECTS) KN7001
* Advanced Neurochemistry with Molecular Neurobiology (15 ECTS) KN8001
* Signal Transduction (15 ECTS) KN8002
Bachelors Degree, including at least 75 ECTS credits in Chemistry, 15 of which must be in Biochemistry. English B (Swedish upper secondary school course) or equivalent, or one of the following tests: IELTS: 6.5 (with no section below 5.5). TOEFL (paper based): 575 (with minimum score 4,5 in the written test). TOEFL (internet based): 90 (with minimum score 20 in the written test). University of Cambridge and Oxford: Certificate in Advanced English or Diploma of English Studies.
|TOEFL paper-based test score:||575|
|TOEFL iBT® test:||90|
You are normally required to take an English Proficiency Test.
Most European Universities recognise the IELTS test.Take IELTS test
Using the form on this page, you can directly ask questions to the contactpersons at the university.
Fill out your contact information and message. The information you fill out in this form will be sent directly to the university. They will reply to you on the e-mail address you provide here.
mastersportal.eu cannot take any responsibility for the answering of contacts or for the content of their replies.